Our top pick for
Rite Aid Corporation is a pharmaceutical retailers business based in the US. Rite Aid Corporation shares (RAD) are listed on the NYSE and all prices are listed in US Dollars. Rite Aid Corporation employs 50,000 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$8.86 - $32.48|
|50-day moving average||$21.21|
|200-day moving average||$17.53|
|Wall St. target price||$18.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-8.61|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Rite Aid Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Rite Aid Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Rite Aid Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.87. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Rite Aid Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Rite Aid Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $460.4 million.
The EBITDA is a measure of a Rite Aid Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$24 billion|
|Operating margin TTM||0.55%|
|Gross profit TTM||$4.7 billion|
|Return on assets TTM||0.89%|
|Return on equity TTM||-15.52%|
|Market capitalisation||$1 billion|
TTM: trailing 12 months
There are currently 8.1 million Rite Aid Corporation shares held short by investors – that's known as Rite Aid Corporation's "short interest". This figure is 7.6% up from 7.5 million last month.
There are a few different ways that this level of interest in shorting Rite Aid Corporation shares can be evaluated.
Rite Aid Corporation's "short interest ratio" (SIR) is the quantity of Rite Aid Corporation shares currently shorted divided by the average quantity of Rite Aid Corporation shares traded daily (recently around 2.5 million). Rite Aid Corporation's SIR currently stands at 3.28. In other words for every 100,000 Rite Aid Corporation shares traded daily on the market, roughly 3280 shares are currently held short.
However Rite Aid Corporation's short interest can also be evaluated against the total number of Rite Aid Corporation shares, or, against the total number of tradable Rite Aid Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Rite Aid Corporation's short interest could be expressed as 0.15% of the outstanding shares (for every 100,000 Rite Aid Corporation shares in existence, roughly 150 shares are currently held short) or 0.1644% of the tradable shares (for every 100,000 tradable Rite Aid Corporation shares, roughly 164 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Rite Aid Corporation.
Find out more about how you can short Rite Aid Corporation stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Rite Aid Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 32
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Rite Aid Corporation's overall score of 32 (as at 12/31/2018) is nothing to write home about – landing it in it in the 58th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Rite Aid Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 5/100
Rite Aid Corporation's environmental score of 5 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Rite Aid Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 5/100
Rite Aid Corporation's social score of 5 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Rite Aid Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 5/100
Rite Aid Corporation's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Rite Aid Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Rite Aid Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Rite Aid Corporation hasn't always managed to keep its nose clean.
|Total ESG score||32|
|Total ESG percentile||57.58|
|Environmental score percentile||5|
|Social score percentile||5|
|Governance score percentile||5|
|Level of controversy||3|
We're not expecting Rite Aid Corporation to pay a dividend over the next 12 months.
Rite Aid Corporation's shares were split on a 1:20 basis on 21 April 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Rite Aid Corporation shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Rite Aid Corporation shares which in turn could have impacted Rite Aid Corporation's share price.
Over the last 12 months, Rite Aid Corporation's shares have ranged in value from as little as $8.855 up to $32.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Rite Aid Corporation's is 0.8869. This would suggest that Rite Aid Corporation's shares are less volatile than average (for this exchange).
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and provides preventative services, such as screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order and specialty pharmacy services, as well as drug benefits under the federal government's Medicare Part D program.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.